Lv31
210 积分 2025-10-24 加入
Research progress of PTP1B inhibitors and degraders
1小时前
求助中
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
2个月前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
4个月前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
4个月前
已完结
Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease
5个月前
已完结
Integrated approach to specimen design for accurate tensile and compressive testing using FEA and experiments
6个月前
已关闭
MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson’s disease
7个月前
已完结
Black Phosphorus Nanosheets Protect Neurons by Degrading Aggregative α‐syn and Clearing ROS in Parkinson's Disease
7个月前
已完结
皖公网安备34019202002308
